Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

Aphria: 6 Aurora Cannabis: 6 Canopy Growth: 6 Hexo Corp: 6 Harvest Health & Recreation: 5 ...

Aphria Inc. was founded in 2013 when the leaders saw a future in cannabis and decided to apply more than 60 years of commercial agriculture and greenhouse expertise to grow a few medical cannabis ...

The market promised tremendous growth potential. Major players such as Canopy Growth (CGC), Aurora Cannabis (ACB), and Aphria (now part of Tilray Brands) quickly established themselves as industry ...

Tilray reported mixed results in its first full quarter after merging with Aphria. The company turned a profit — posting a better-than-expected $33.6 million in net income, but missed Wall ...

Tilray rallied as much as 27.2% on Wednesday after the company announced plans to merge with Aphria and create the world's biggest marijuana company. The two firms announced Wednesday they agreed ...

The Beverage business has been beer, though the company will soon introduce THC beverages from industrial hemp in the U.S. The Distribution business, which it picked up when it bought Aphria ...

The three largest publicly traded Canadian companies—Canopy Growth, Aurora Cannabis, and Aphria Inc., which all trade on the Toronto Stock Exchange—currently have market caps of approximately ...

We have the solution to Wordle on July 16, as well as some helpful hints to help you figure out the answer yourself, right here. We’ve placed the answer at the bottom of the page, so we don’t ...

In 2018, it became the first major cannabis stock to trade on U.S. exchanges. And after a 2020 merger with Aphria, it is now one of the largest companies in both the medical marijuana and ...

At Aphria RX, our German cultivation and processing facility, we received the very first commercial cannabis cultivation license and commercial distribution license issued in Germany under the new ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...